Physician profile
Soheil Rostami
NPI 1396237061
$4,571.20
in general payments reported to CMS, 2019-2025
7 companies · $2,851 in 2025
The $2,851 reported for 2025 was more than what 92% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2023: $1,154 · 2024: $458 · 2025: $2,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Travel and Lodging: $1,256 · Education: $317 · Entertainment: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.18 |
| Travel and Lodging | $1,255.94 |
| Education | $317.20 |
| Entertainment | $221.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,431.34 | 2024-2025 | |
| Straumann USA LLC | $1,328.04 | 2023-2025 | |
| Stryker Corporation | $493.41 | 2023-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial |
| Vertex Pharmaceuticals Incorporated | $124.94 | 2025 | |
| Biohorizons Implant Systems INC. | $108.46 | 2021 | |
| Axogen | $70.87 | 2023 | Avance Nerve Graft |
| Kowa Pharmaceuticals America, INC. | $14.14 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soheil Rostami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.